Founding Members
The ICDA Founding Members are 83 scientists who have participated in the meetings and discussions that have given rise to ICDA’s vision and launch.
Goncalo Abecasis
Regeneron Genetics Center
USA
Carl Anderson
Wellcome Sanger Institute
UK
Ole Andreassen
University of Oslo
Norway
Philip Awadalla
University of Toronto
Canada
Orli G. Bahcall
Nature
USA
Cori Bargmann
Chan Zuckerberg Initiative
USA
Kathleen Barnes
University of Colorado Anschutz Medical Campus
USA
Ewan Birney
EMBL-EBI
UK
Michael Boehnke
University of Michigan
USA
Søren Brunak
University of Copenhagen
Denmark
John Chambers
Lee Kong Chian School of Medicine, Imperal College
UK, Singapore
Zhengming Chen
University of Oxford
UK, Hong Kong
Judy Cho
Icahn School of Medicine at Mount Sinai
USA
Melina Claussnitzer
Harvard Medical School, Massachusetts General Hospital, The Broad Institute of MIT and Harvard
USA
Rory Collins
University of Oxford
UK
Nancy Cox
Vanderbilt Genetics Institute
USA
Mark Daly
Institute for Molecular Medicine Finland (FIMM), Massachusetts General Hospital, Broad Institute of MIT and Harvard
USA, Finland
John Danesh
University of Cambridge, Wellcome Sanger Institute
UK
George Davey Smith
University of Bristol
UK
Paul de Bakker
Vertex Pharmaceuticals
USA
Joshua Denny
Vanderbilt University
USA
Manolis Dermitzakis
GlaxoSmithKline
Switzerland
Peter Donnelly
Genomics plc
UK
Audrey Duncanson
Wellcome Trust
UK
Ian Dunham
Open Targets
UK
Michael Dunn
Wellcome Trust
UK
Jonathan Emberson
University of Oxford
UK
Jesse Engreitz
Harvard University, Broad institute of MIT and Harvard
USA
Tonu Esko
University of Tartu
Estonia
Paul Flicek
EMBL-EBI
UK
Caroline Fox
Merck & Co.
USA
Lude Franke
University Medical Centre Groningen
Netherlands
Nelson Freimer
University of California Los Angeles
USA
Daniel Freitag
Bayer Pharmaceuticals
Germany
David Glazer
Verily Life Sciences
USA
Anna Gloyn
University of Oxford, Wellcome Centre for Human Genetics
UK
Eric Green
National Human Genome Research Institute
USA
John Hardy
University College London
UK
Matthew Hurles
Wellcome Sanger Institute
UK
Carolyn M. Hutter
National Human Genome Research Institute, National Institutes of Health
USA
Howard Jacob
AbbVie Inc.
USA
Prabhat Jha
University of Toronto
Canada
Sally John
Biogen
USA
Katherine Klinger
Sanofi Genzyme
USA
Anshul Kundaje
Stanford University
USA
Eric Lander
Broad Institute of MIT and Harvard
On Leave
USA
John Landers
University of Massachusetts Medical School
USA
Tuuli Lappalainen
New York Genome Center
USA
Cathryn Lewis
King's College London
UK
Cecilia Lindgren
University of Oxford
UK
Ruth Loos
Icahn School of Medicine at Mount Sinai
USA
Dorthe Lundsgaard
Novo Nordisk
Denmark
Daniel MacArthur
Broad institute of MIT and Harvard, Massachusetts General Hospital, Harvard Medical School
USA
Mark McCarthy
Genentech
USA, UK
Benjamin Neale
Massachusetts General Hospital, Harard Medical School, Broad institute of MIT and Harvard
USA
Michael O'Donovan
Cardiff University
UK
Yukinori Okada
Osaka University Graduate School of Medicine
Japan
Aarno Palotie
Institute for Molecular Medicine Finland (FIMM)
Finland
Helen Parkinson
EMBL-EBI
UK
Anthony Philippakis
Broad institute of MIT and Harvard, Brigham and Women's Hospital
USA
Robert Plenge
Celgene
USA
Nadia Rosenthal
The Jackson Laboratory, Imperial College
UK
Nadeem Sarwar
Eisai Inc.
USA
Marcus Schindler
Novo Nordisk
Denmark
Pak Sham
University of Hong Kong
Hong Kong
Andrew Singleton
National Human Genome Research Institute
USA
Jim Smith
Wellcome Trust, Francis Crick Institute
UK
Morten Sogaard
Pfizer
USA
Nicole Soranzo
Wellcome Sanger Institute
UK
Kári Stefánsson
deCODE genetics
Iceland
Patrick Sullivan
University of North Carolina, Karolinska Institute
USA, Sweden
Sandor Szalma
Takeda Pharmaceuticals
USA
E Shyong Tai
Singapore Health Services, National University Hospital, National University of Singapore
Singapore
Sarah Teichmann
Wellcome Sanger Institute, University of Cambridge
UK
Nicki Tiffin
South African National Bioinformatics Institute, University of the Western Cape
South Africa
John Todd
University of Oxford, Wellcome Centre for Human Genetics
UK
David van Heel
Queen Mary University of London
UK
Natalia Volfovsky
Simons Foundation
USA
Niels-Henrik von Holstein-Rathlou
Novo Nordisk Foundation
Denmark
Cisca Wijmenga
University College Groningen
Netherlands
Ramnik Xavier
Broad institute of MIT and Harvard, Massachusetts General Hospital, Harvard Medical School, Massachusetts Institute of Technology
USA
Eleftheria Zeggini
Helmholtz Zentrum München
Germany